SUSAN HODGE: Open Payments
NPI 1942305156 · BARBOURVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 27 payments from 13 companies in 2025. Trend: 2023 $805 · 2024 $990 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $153 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| BETA BIONICS, INC. | 2 | $51 |
| Lilly USA, LLC | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: ELIQUIS, FARXIGA, iLet Bionic Pancreas, MOUNJARO, Kerendia, CAPLYTA, Auvelity, VERQUVO.
Industry payments across KY — which companies pay providers there.
